Journal ArticleOPEN ACCESS

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

Nature Communications (2024) 15(1)
DOI: 10.1038/s41467-024-45595-3
29Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An important contribution of cancer associated fibroblasts (CAFs) in regulating chemoresistance has been reported. Here the authors investigate the impact of chemotherapy on CAF subsets in patients with high-grade serous ovarian cancer, suggesting that residual ANTXR1+ myofibroblasts are associated with inhibition of anti-tumor immunity.

Cite

CITATION STYLE

APA

Licaj, M., Mhaidly, R., Kieffer, Y., Croizer, H., Bonneau, C., Meng, A., … Mechta-Grigoriou, F. (2024). Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-45595-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free